1

The-Pharma-Market-Access-Landscape-in-the-Middle-East-and-North-Africa-The-Next-Ten-Years-Image-2

05.25.2020

Related Articles

The Supra-SMART Framework: Developing productive objectives on value based healthcare.

Setting objectives focused on value based healthcare is demanding. You’re working in a field that is complex and involves multiple processes and stakeholders, and you’re trying to shape objectives that help with expanding value based healthcare in constructive ways. You’re weighing the value story of a new healthcare technology, learning how value based healthcare works, […]

Read all
What is Health Technology Assessment?

Introduction Health technology assessment is the “multidisciplinary field of policy analysis, studying the medical, economic, social and ethical implications of development, diffusion, and use of health technology” (INAHTA, 2018). It aims to improve access to innovative treatments whilst rewarding producers of new technologies for their research and development efforts. Health technology assessments test the value […]

Read all
Global Pharma Market Access: Pharmacoeconomics in Middle-income Countries

Many middle-income countries such as Egypt, South Africa, Malaysia, Thailand, and Brazil have pharmacoeconomic guidelines. These follow the recommendations by the International Society for Pharmacoeconomics and Outcomes Research but include country-specific differences. The variations respond to changes in how governments apply pharmacoeconomics and determine market access to pharmaceuticals and medical devices. This is also determined […]

Read all
Read all articles